Rüdiger Kaspera

1.4k total citations
23 papers, 1.0k citations indexed

About

Rüdiger Kaspera is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Rüdiger Kaspera has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Rüdiger Kaspera's work include Pharmacogenetics and Drug Metabolism (10 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Microbial Natural Products and Biosynthesis (4 papers). Rüdiger Kaspera is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Microbial Natural Products and Biosynthesis (4 papers). Rüdiger Kaspera collaborates with scholars based in United States, Germany and Japan. Rüdiger Kaspera's co-authors include Rodney Croteau, Rheem A. Totah, Raymond E.B. Ketchum, Mark R. Wildung, Robert M. Long, Kristin D. Marciante, Ulrich Krings, Ralf G. Berger, Nanzad Tsevegsüren and Ralf G. Berger and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Applied Microbiology and Biotechnology.

In The Last Decade

Rüdiger Kaspera

23 papers receiving 1.0k citations

Peers

Rüdiger Kaspera
Ute M. Kent United States
F.Peter Guengerich United States
Kostas P. Vatsis United States
Ute M. Kent United States
Rüdiger Kaspera
Citations per year, relative to Rüdiger Kaspera Rüdiger Kaspera (= 1×) peers Ute M. Kent

Countries citing papers authored by Rüdiger Kaspera

Since Specialization
Citations

This map shows the geographic impact of Rüdiger Kaspera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüdiger Kaspera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüdiger Kaspera more than expected).

Fields of papers citing papers by Rüdiger Kaspera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rüdiger Kaspera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüdiger Kaspera. The network helps show where Rüdiger Kaspera may publish in the future.

Co-authorship network of co-authors of Rüdiger Kaspera

This figure shows the co-authorship network connecting the top 25 collaborators of Rüdiger Kaspera. A scholar is included among the top collaborators of Rüdiger Kaspera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rüdiger Kaspera. Rüdiger Kaspera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kaspera, Rüdiger, et al.. (2020). Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor. European Journal of Drug Metabolism and Pharmacokinetics. 46(1). 141–153. 16 indexed citations
3.
Roberts, Arthur G., Rüdiger Kaspera, Isolde Le Trong, et al.. (2015). The role of cytochrome P450 BM3 phenylalanine-87 and threonine-268 in binding organic hydroperoxides. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(4). 669–677. 10 indexed citations
4.
Kaspera, Rüdiger, Brian J. Kirby, Ann C. Collier, et al.. (2014). Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo. Biochemical Pharmacology. 91(1). 109–118. 38 indexed citations
5.
Yang, Bin, Michelle L. Lamb, Tao Zhang, et al.. (2014). Discovery of Potent KIFC1 Inhibitors Using a Method of Integrated High-Throughput Synthesis and Screening. Journal of Medicinal Chemistry. 57(23). 9958–9970. 35 indexed citations
6.
Tamraz, Bani, Hisayo Fukushima, Alan R. Wolfe, et al.. (2013). OATP1B1-related drug–drug and drug–gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis. Pharmacogenetics and Genomics. 23(7). 355–364. 47 indexed citations
7.
Kaspera, Rüdiger, et al.. (2013). Activity, Inhibition, and Induction of Cytochrome P450 2J2 in Adult Human Primary Cardiomyocytes. Drug Metabolism and Disposition. 41(12). 2087–2094. 49 indexed citations
8.
Raccor, Brianne S. & Rüdiger Kaspera. (2013). Extra-Hepatic Isozymes from the CYP1 and CYP2 Families as Potential Chemotherapeutic Targets. Current Topics in Medicinal Chemistry. 13(12). 1441–1453. 12 indexed citations
9.
Takakusa, Hideo, Isaac Mohar, Terrance J. Kavanagh, et al.. (2012). Protein tyrosine nitration of mitochondrial carbamoyl phosphate synthetase 1 and its functional consequences. Biochemical and Biophysical Research Communications. 420(1). 54–60. 10 indexed citations
10.
Lee, Caroline A., Rüdiger Kaspera, Ying Jiang, et al.. (2012). Identifying a Selective Substrate and Inhibitor Pair for the Evaluation of CYP2J2 Activity. Drug Metabolism and Disposition. 40(5). 943–951. 78 indexed citations
11.
Kaspera, Rüdiger, et al.. (2012). Cytochrome P450BM-3 reduces aldehydes to alcohols through a direct hydride transfer. Biochemical and Biophysical Research Communications. 418(3). 464–468. 5 indexed citations
12.
Floyd, James S., Rüdiger Kaspera, Kristin D. Marciante, et al.. (2012). A Screening Study of Drug–Drug Interactions in Cerivastatin Users: An Adverse Effect of Clopidogrel. Clinical Pharmacology & Therapeutics. 91(5). 896–904. 41 indexed citations
13.
Kaspera, Rüdiger, et al.. (2011). Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5. Biochemical Pharmacology. 82(6). 681–691. 37 indexed citations
14.
Kaspera, Rüdiger, Suresh Babu Naraharisetti, Bani Tamraz, et al.. (2010). Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenetics and Genomics. 20(10). 619–629. 21 indexed citations
15.
Kaspera, Rüdiger, Jonathan L. Cape, Juan A. Faraldos, Raymond E.B. Ketchum, & Rodney Croteau. (2010). Synthesis and in vitro evaluation of taxol oxetane ring D precursors. Tetrahedron Letters. 51(15). 2017–2019. 12 indexed citations
16.
Kaspera, Rüdiger & Rheem A. Totah. (2009). Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology. Expert Opinion on Drug Metabolism & Toxicology. 5(7). 757–771. 67 indexed citations
17.
Kaspera, Rüdiger & Rodney Croteau. (2006). Cytochrome P450 oxygenases of Taxol biosynthesis. Phytochemistry Reviews. 5(2-3). 433–444. 100 indexed citations
18.
Croteau, Rodney, Raymond E.B. Ketchum, Robert M. Long, Rüdiger Kaspera, & Mark R. Wildung. (2006). Taxol Biosynthesis and Molecular Genetics. Phytochemistry Reviews. 5(1). 75–97. 330 indexed citations
19.
Krings, Ulrich, et al.. (2005). Biotransformation ofγ-terpinene usingStemphylium botryosum(Wallroth) yieldsp-mentha-1,4-dien-9-ol, a novel odorous monoterpenol. Biocatalysis and Biotransformation. 23(6). 457–463. 4 indexed citations
20.
Kaspera, Rüdiger, Ulrich Krings, Nanzad Tsevegsüren, & Ralf G. Berger. (2004). Bioconversion of (+)-valencene in submerged cultures of the ascomycete Chaetomium globosum. Applied Microbiology and Biotechnology. 67(4). 477–483. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026